Business / Finance

RSS

Limelight Health secures $3 million in Series A funding from MassMutual Ventures

Limelight Health, provider of mobile enterprise technology for the health insurance industry, announced today it has received $3 million in Series A funding from MassMutual Ventures, the corporate venture capital arm of Massachusetts Mutual Life Insurance Company, and AXA Strategic Ventures.

20 Jul 2015

Valeant Pharmaceuticals enters into definitive agreement to acquire Amoun Pharmaceutical

Valeant Pharmaceuticals International, Inc. today announced that it has entered into a definitive agreement under which Valeant will acquire Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical, for consideration of approximately US$800 million, plus contingent payments.

17 Jul 2015

Mindray Medical announces completion of Wuhan Dragonbio acquisition

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it completed the acquisition of the remaining stake in Wuhan Dragonbio Surgical Implant Co., Ltd. for a total cash consideration of RMB 435 million (approximately US$ 70.2 million) pursuant to the terms of the definitive agreement entered into on July 7, 2015.

From Mindray 17 Jul 2015

Rowan University, Bamboo Therapeutics partner to combat Canavan disease

Rowan University and Bamboo Therapeutics, Inc. have entered into an asset transfer agreement to commercialize a novel gene therapy for the treatment of Canavan disease. A rare but devastating neurological disease that tragically takes a child's life by age 10, Canavan disease is one of the most common and complex degenerative cerebral diseases in infants.

17 Jul 2015

Medtronic launches GenCut Core Biopsy System for minimally invasive use with the superDimension navigation system for lung tissue biopsies

Medtronic now offers the GenCut(TM) core biopsy system, a unique lung tissue biopsy tool for use with the superDimension(TM) navigation system. The superDimension(TM) system enables a minimally invasive approach to accessing difficult-to-reach areas of the lung, which can aid in the diagnosis of lung cancer.

From Medtronic 17 Jul 2015

OGT’s popular ESHG workshop free to view online

Oxford Gene Technology (OGT), The Molecular Genetics Company, has made its European Human Genetics (ESHG) Conference workshop freely available to view online.

From Oxford Gene Technology 16 Jul 2015

Medstor - maximising storage and minimising waste in Glasgow

Medstor, known for its innovative approach to designing stylish, efficient healthcare storage solutions, that also support hospital infection control measures, has recently finished work at the impressive new Queen Elizabeth University Hospital and Royal Hospital for Children.

16 Jul 2015

Impingement testing added to Lucideon’s orthopedic implant testing services

Lucideon, the international materials technology company, has added impingement testing to its range of services for orthopedic implant manufacturers.

From Lucideon 16 Jul 2015

TechSource National announces acquisition of IMEBASE product

TechSource National is pleased to announce the asset purchase of IMEBASE, a web-based application designed to create, track and complete independent medical examinations, medical peer reviews and other medical evaluative services.

16 Jul 2015

Protagonist Therapeutics closes $40 million Series C financing

Protagonist Therapeutics, Inc., a company developing novel, orally stable peptide therapeutics for gastrointestinal diseases and disorders, today announced the closing of a $40 million Series C financing.

16 Jul 2015

AMRI purchases Gadea Pharmaceutical Group for $174 million

AMRI today announced that it has acquired all the outstanding shares of Gadea Pharmaceutical Group, a privately-held company located in Valladolid, Spain, specializing in technically complex active pharmaceutical ingredients (APIs) and finished drug product.

16 Jul 2015

Immunocore completes $320 million (£205 million) private financing round

Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune disease, today announced the completion of a US $320 million (GBP £205 million) private financing round.

16 Jul 2015

Apogenix signs licensing agreement with CANbridge to commercialize APG101 in China, Macao and Hong Kong

Apogenix, a next generation immuno-oncology company, announced today that it has entered into an exclusive licensing agreement with CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, for the development and commercialization of lead immuno-oncology drug candidate APG101 in China, Macao, and Hong Kong.

15 Jul 2015

AnaptysBio announces completion of oversubscribed $40MM Series D financing round

AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology, today announced the completion of an oversubscribed $40MM Series D financing round.

15 Jul 2015

GENALICE, KeyGene jointly mark significant mutual benefits of first two years of partnerships

Today, molecular genetics Ag Biotech company KeyGene and biomedical big data solutions company GENALICE, jointly mark the significant mutual benefits of their first two years of partnerships, running GENALICE MAP in full production as their preferred tool for primary Next-Generation Sequencing (NGS) data analysis.

15 Jul 2015

Electrum Partners agrees to help develop ATTIS' business operations

The Attis Group, Inc., an Oregon-based cannabis cultivator, processor and dispensary owner, has entered into an agreement with Las Vegas, Nevada firm Electrum Partners to help develop plans to expand ATTIS' business operations.

15 Jul 2015

Rubicon Genomics completes $2 million growth capital financing

Rubicon Genomics, Inc., a provider of innovative pre-analytical reagent kits to improve the performance of genomic analytical platforms and enable the use of liquid biopsies, today announced that it has completed a $2 million growth capital financing.

15 Jul 2015

Efficient, sensitive and robust Chromatin immunoprecipitation methods

Chromatrap®, a business unit of Porvair Sciences, has produced a new 10-page brochure that provides an informative introduction to chromatin immunoprecipitation (ChIP) technology and a detailed comparison of traditional bead based and Chromatrap® solid state ChIP technologies.

From Chromatrap® - Porvair Sciences Ltd 14 Jul 2015

Isis Pharmaceuticals receives $2.15 million milestone payment to advance ISIS-SMN Rx study in children with SMA

Isis Pharmaceuticals, Inc. announced today that it has earned a $2.15 million milestone payment from Biogen related to advancing the ongoing pivotal Phase 3 study (CHERISH) evaluating ISIS-SMN Rx in children with spinal muscular atrophy (SMA).

14 Jul 2015

Imperial Innovations secures EIB loan to support investment in UK biotech, life science sector

Imperial Innovations Group has secured a new GBP 50 million loan from the European Investment Bank to support investment in the UK biotech and life science sector.

14 Jul 2015

Business / Finance

Limelight Health secures $3 million in Series A funding from MassMutual Ventures

Valeant Pharmaceuticals enters into definitive agreement to acquire Amoun Pharmaceutical

Mindray Medical announces completion of Wuhan Dragonbio acquisition

Rowan University, Bamboo Therapeutics partner to combat Canavan disease

Medtronic launches GenCut Core Biopsy System for minimally invasive use with the superDimension navigation system for lung tissue biopsies

OGT’s popular ESHG workshop free to view online

Medstor - maximising storage and minimising waste in Glasgow

Impingement testing added to Lucideon’s orthopedic implant testing services

TechSource National announces acquisition of IMEBASE product

Protagonist Therapeutics closes $40 million Series C financing

AMRI purchases Gadea Pharmaceutical Group for $174 million

Immunocore completes $320 million (£205 million) private financing round

Apogenix signs licensing agreement with CANbridge to commercialize APG101 in China, Macao and Hong Kong

AnaptysBio announces completion of oversubscribed $40MM Series D financing round

GENALICE, KeyGene jointly mark significant mutual benefits of first two years of partnerships

Electrum Partners agrees to help develop ATTIS' business operations

Rubicon Genomics completes $2 million growth capital financing

Efficient, sensitive and robust Chromatin immunoprecipitation methods

Isis Pharmaceuticals receives $2.15 million milestone payment to advance ISIS-SMN Rx study in children with SMA

Imperial Innovations secures EIB loan to support investment in UK biotech, life science sector

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News